TPCS,
Thank you for your post, I must admit I beg to differ.
At the AGM the Board said 3 Mths being Mid Feb.
The last two announcements have showed clear progress.
• Mitisubishi after a visit in late Dec has progressed the funding agreement to “detail legal and commercial documentation” Imagine the size of the Mitisubishi legal team who have experience with multimillion dollar deals.
• CNQ has “ significantly advanced discussions with separate supportive debt funding groups” to “detail commercial document stage”
• Mitisubishi have advanced CNQ $1.0 Million Dollars at say $0.135 per share.
• CNQ is dealing with Mitisubishi not some tin pot company and due diligence has continued and extended period of time with key Mitisubishi technical people visiting site late Dec. I cannot see Mitisubishi walking away. Japanese do not accept failure.
• I am confident the Mitisubishi Lawyers would be approving all CNQ announcements including the Executive summary page 2 of the activity report and HOPEFULLLY a fully funded project announcement could be expected from this update.
• Mitisubishi are slow very methodical and would be hands on with the plant Design & Construction and will not accept failure.
• Note we only got the Government approvals in December.
• The forecasted March Qtr cash flow reflects a confidence in the funding agreements being signed.
• Mitisubishi are an incredibly large multi national with an A1 reputation and they have spent over 12 Months dealing with a small cap like CNQ. Clearly they need a Guaranteed supply of Tungsten and they are prepared to invest $$ to secure supply.
• Imagine if BHP was negotiating with CNQ. Mitisubish is not much smaller and they are currently funding Iron ore projects in W.A.
The small $$ trades sending the CNQ price down 5% is very frustrating WHY?
Yes I am frustrated but I see a light.
Please DYOR.
- Forums
- ASX - By Stock
- EQR
- Ann: Mitsubishi Funding & MoU Update
Ann: Mitsubishi Funding & MoU Update , page-20
Featured News
Add EQR (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $105.1M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 134830 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 75007 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 134830 | 0.046 |
2 | 209366 | 0.045 |
2 | 294761 | 0.042 |
1 | 65000 | 0.041 |
1 | 127948 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 75007 | 1 |
0.049 | 199999 | 1 |
0.051 | 24999 | 1 |
0.052 | 31165 | 1 |
0.055 | 100000 | 1 |
Last trade - 11.00am 15/11/2024 (20 minute delay) ? |
Featured News
EQR (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online